The Burrill Global Select Healthcare Fund, L.P. is a private equity fund focused exclusively on human healthcare from biotechnology, pharmaceuticals, devices, healthcare information technology companies, services and CROs. This Fund was formed to capitalize on Burrill’s unique investment platform and the opportunities created by capital market inefficiencies within the healthcare field; its focus is on investing in buyouts, spin-outs, and recaps, as well as undervalued public companies.

The capital markets are highly inefficient in their treatment of healthcare companies, resulting in significant valuation differentials and investment opportunities. The Burrill Global Select Healthcare Fund seeks out the most compelling private equity opportunities in the healthcare world created by this intersection of science, capital market inefficiency, and the very large unmet medical and health needs of the world’s population.